For people living with depression that hasn’t improved with traditional medications, learning about new treatment options can feel overwhelming. Spravato® (esketamine) nasal spray is one such option that often raises important questions, especially around safety, effectiveness, and who it’s right for.
Below, we answer the most common questions patients and providers ask when searching for a Spravato® treatment center or a Spravato® treatment center near me.
Q. What Is Spravato® (Esketamine) Nasal Spray?
A. Spravato® is an FDA-approved prescription nasal spray used to treat treatment-resistant depression and depression with acute suicidal ideation. It is derived from esketamine, a compound related to ketamine, and works differently from traditional antidepressants.
Rather than primarily affecting serotonin or norepinephrine, Spravato® targets glutamate pathways in the brain, which play a key role in mood regulation and neuroplasticity.
RELATED ARTICLE: Medication Management Isn’t Just Prescribing
Q. Who Is Spravato® For?
A. Spravato® is typically considered for adults who:
- Have tried two or more antidepressants without adequate relief
- Experience persistent depressive symptoms despite ongoing treatment
- Need a treatment option with a faster onset of effect
- Require closely monitored, structured psychiatric care
It may be especially appropriate when depression is severe, longstanding, or impairing daily functioning.
Q. How Is Spravato® Different From Traditional Antidepressants?
A. Traditional antidepressants are taken daily and often take weeks to show benefit. Spravato® is administered in a clinical setting, usually once or twice weekly during an initial treatment phase, with ongoing maintenance based on response.
Many patients notice symptom improvement sooner than with oral medications, though individual responses vary.
Q. What Happens During a Spravato® Treatment Visit?
A. At a certified Spravato® treatment center:
- The nasal spray is self-administered under medical supervision
- Patients are monitored on site for approximately two hours
- Blood pressure, symptoms, and side effects are closely observed
- Patients must arrange transportation home after treatment
This structured setting is part of what makes Spravato® distinct from standard medication management.
Q. Is Spravato® Safe?
A. Spravato® is FDA-approved and subject to a Risk Evaluation and Mitigation Strategy (REMS) program to ensure safe use. Common side effects may include dizziness, dissociation, nausea, or temporary blood pressure changes, which are why in-clinic monitoring is required.
At Junction Brain Health, treatment decisions are made carefully, with individual risk-benefit discussions and ongoing assessment throughout care.
Q. What About Spravato® and Women’s Mental Health?
A. Spravato® may be considered in complex, hormone-sensitive cases, including patients experiencing mood symptoms during reproductive transitions. However:
- It is not routinely used during pregnancy
- Breastfeeding considerations require case-by-case evaluation
- Collaboration with OB-GYN providers is essential when reproductive health factors are involved
This makes referral to an experienced, coordinated care team especially important.
RELATED ARTICLE: What Coming Out of Major Depressive Disorder Can Feel Like
Q. Can Spravato® Be Used Alongside Other Treatments?
A. Yes. Spravato® is often used in combination with an oral antidepressant and may be part of a broader treatment plan that includes psychotherapy, psychiatric medication management, or interventional treatments like TMS therapy.
At Junction Brain Health, care is structured so patients are not siloed into a single modality.
RELATED ARTICLE: Searching for TMS Therapy Near Me? Find the Right Clinic and What to Ask
Q. How Do I Find a Spravato® Treatment Center Near Me?
A. Not all clinics are certified to provide Spravato®. When searching for a Spravato® clinic near you, look for:
- REMS-certified providers
- In-clinic monitoring and follow-up
- Experience treating treatment-resistant depression
- Clear communication with referring providers
Junction Brain Health offers Spravato® at select locations as part of a comprehensive, evidence-based care model.
Q. Is Spravato® a “Last Resort”?
A. Not necessarily. While it is often used after other treatments haven’t worked, Spravato® is best viewed as another evidence-based option, not a failure of previous care.
For the right patients, it can represent a meaningful shift in how depression is treated.
RELATED ARTICLE: How to Overcome Barriers to Depression Treatment
A Different Path Forward
Living with depression that doesn’t respond to standard treatment can be exhausting and isolating. Spravato® offers a medically supervised option that works differently than traditional medications and may help when other approaches have fallen short.
If you’re exploring care for yourself or a patient and searching for a trusted Spravato® treatment center, Junction Brain Health is here to help you understand your options and determine what comes next.